Identification of a Novel Coxsackievirus A16 Strain Isolated from the Clinic HFMD Sample in Hubei Province in 2010
Advances in Bioscience and Bioengineering
Volume 4, Issue 5, October 2016, Pages: 51-58
Received: Aug. 25, 2016; Accepted: Sep. 26, 2016; Published: Oct. 15, 2016
Views 3170      Downloads 101
Authors
Tingting Xu, State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China
Weixia Wang, State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China
Songya Lyu, State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China
Article Tools
Follow on us
Abstract
Enterovirus 71 (EV71) and Coxsackievirus A16 (CoxA16) are two major pathogens of Hand, foot and mouth disease (HFMD) that epidemic periodically among children and cause deaths occasionally. There is no effective vaccine or drug for HFMD to date. Here the whole genome of a clinic virus isolate GDV126(China Center for Type Culture Collection, CCTCC)of HFMD was sequenced in Hubei 2010. Phylogenetic analysis demonstrates that the virus belongs to CoxA16. Both phylogenetic and recombination analysis of GDV126 showed that the GDV126 was a recombinant strain of CoxA16. In addition, GDV126 had different cell tropism from EV71. This work demonstrated the genetic variations and evolution of the HFMD pathogens and implicated complication to prevent the disease.
Keywords
Coxsackievirus A16, Hand, Foot and Mouth Diseases, Phylogenetic Analysis
To cite this article
Tingting Xu, Weixia Wang, Songya Lyu, Identification of a Novel Coxsackievirus A16 Strain Isolated from the Clinic HFMD Sample in Hubei Province in 2010, Advances in Bioscience and Bioengineering. Vol. 4, No. 5, 2016, pp. 51-58. doi: 10.11648/j.abb.20160405.12
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Ho M, Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect, 2000. 33 (4): 205-16.
[2]
Cardosa M J, Perera D, Brown B A et al., Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis, 2003. 9 (4): 461-8.
[3]
Chan L G, Parashar U D, Lye M S et al., Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis, 2000. 31 (3): 678-83.
[4]
Perez-Velez C M, Anderson M S, Robinson C C et al., Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007. 45 (8): 950-7.
[5]
Nagy G, Takatsy S, Kukan E et al., Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982. 71 (3): 217-27.
[6]
Shindarov L M, Chumakov M P, Voroshilova M K et al., Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979. 23 (3): 284-95.
[7]
Solomon T, Lewthwaite P, Perera D et al., Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis, 2010. 10 (11): 778-90.
[8]
Mauleekoonphairoj J, Vongpunsawad S, Puenpa J et al., Complete genome sequence analysis of enterovirus 71 isolated from children with hand, foot, and mouth disease in Thailand, 2012-2014. Virus Genes, 2015. 51 (2): 290-3.
[9]
Liu Y, Zhang F, Fu C et al., Combination of intratypic and intertypic recombinant events in EV71: a novel evidence for the "triple-recombinant" strains of genotype A viruses in Mainland China from 2008 to 2010. Virus Genes, 2015. 50 (3): 365-74.
[10]
Li R, Liu L, Mo Z et al., An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med, 2014. 370 (9): 829-37.
[11]
Zhu F, Xu W, Xia J et al., Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med, 2014. 370 (9): 818-28.
[12]
Yip C C, Lau S K, Zhou B et al., Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol, 2010. 155 (9): 1413-24.
[13]
Yang T.Xie T H.Song et al., Sensitivities of five kinds of cells to coxsackievirus A16 and enterovirus 71. International Journal of Biologicals,2015(4)
[14]
Simmonds P and Welch J, Frequency and dynamics of recombination within different species of human enteroviruses. J Virol, 2006. 80 (1): 483-93.
[15]
Mao Q, Wang Y, Yao X et al., Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother, 2014. 10 (2): 360-7.
[16]
Sun T, Liu Y, Zhang Y et al., Molecular phylogeny of coxsackievirus A16. J Clin Microbiol, 2014. 52 (10): 3829-30.
[17]
Zhao K, Han X, Wang G et al., Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg Infect Dis, 2011. 17 (8): 1537-40.
[18]
McWilliam Leitch E C, Cabrerizo M, Cardosa J et al., The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71. J Virol, 2012. 86 (5): 2676-85.
[19]
Chen X, Zhang Q, Li J et al., Analysis of recombination and natural selection in human enterovirus 71. Virology, 2010. 398 (2): 251-61.
[20]
Wang X, Zhu C, Bao W et al., Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One, 2012. 7 (3): e32405.
[21]
Liu Q, Ku Z, Cai Y et al., Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods, 2011. 173 (1): 115-20.
[22]
Chen X, Tan X, Li J et al., Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS One, 2013. 8 (12): e82861.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186